Rapid differentiation of hiPSCs into functional oligodendrocytes using an OLIG2 synthetic modified messenger RNA.
Wenbin DengZhihua YangRui WangFumei HeRong YanYidi ZhangLiying YuWenbing DengYichu NiePublished in: Communications biology (2022)
Transcription factors (TFs) have been introduced to drive the highly efficient differentiation of human-induced pluripotent stem cells (hiPSCs) into lineage-specific oligodendrocytes (OLs). However, effective strategies currently rely mainly on genome-integrating viruses. Here we show that a synthetic modified messenger RNA (smRNA)-based reprogramming method that leads to the generation of transgene-free OLs has been developed. An smRNA encoding a modified form of OLIG2, in which the serine 147 phosphorylation site is replaced with alanine, OLIG2 S147A , is designed to reprogram hiPSCs into OLs. We demonstrate that repeated administration of the smRNA encoding OLIG2 S147A lead to higher and more stable protein expression. Using the single-mutant OLIG2 smRNA morphogen, we establish a 6-day smRNA transfection protocol, and glial induction lead to rapid NG2 + OL progenitor cell (OPC) generation (>70% purity) from hiPSC. The smRNA-induced NG2 + OPCs can mature into functional OLs in vitro and promote remyelination in vivo. Taken together, we present a safe and efficient smRNA-driven strategy for hiPSC differentiation into OLs, which may be utilized for therapeutic OPC/OL transplantation in patients with neurodegenerative disease.
Keyphrases
- induced pluripotent stem cells
- highly efficient
- endothelial cells
- transcription factor
- high glucose
- protein kinase
- randomized controlled trial
- diabetic rats
- loop mediated isothermal amplification
- stem cells
- nucleic acid
- mesenchymal stem cells
- gene expression
- neuropathic pain
- spinal cord
- drug induced
- genome wide identification